TAIHO PHARMACEUTICAL Overview
Upcoming Projects (TAIHO PHARMACEUTICAL)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (TAIHO PHARMACEUTICAL)
-
Discussing the results from the pivotal Phase 2b REZILIENT1 trial evaluating zipalertinib in patients with EGFR Exon 20 insertion mutation–positive non-small cell lung cancer (NSCLC) who have received prior systemic therapy.
Tickers: TAIHO PHARMACEUTICAL, CGEM
Executed On: Jun 16, 2025 at 01:15 PM EDT -
Discussing the potential of Lytgobi(futibatinib) in iCCA and the results from the primary analysis of the global Phase 2 FOENIX*-CCA2 trial in light of the recent accelerated FDA approval
Tickers: OTSKY, Taiho Pharmaceutical
Executed On: Dec 06, 2022 at 10:00 AM EST
Upcoming & Overdue Catalysts (TAIHO PHARMACEUTICAL)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (TAIHO PHARMACEUTICAL)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
